Colin Hyslop

Colin Hyslop’s practice focusses primarily on intellectual property litigation. Colin earned his J.D. from Western University, as well both Bachelor’s and Master's degrees in Biochemistry from Queen's University and the University of Calgary, respectively. Colin began his legal career clerking at the Federal Court of Canada, where he gained invaluable insight into the judicial process, before being called to the Ontario Bar in 2019. He then worked in intellectual property litigation at a prominent international full-service law firm and an international intellectual property boutique. Colin has worked on cases involving all varieties of intellectual property and different technological fields, including the pharmaceutical sector.

Education

• J.D., Western University
• M.Sc., Biochemistry, University of Calgary
• B.Sc. (Hons), Biochemistry, Queen’s University

Bar Admission

• Ontario, 2019

Publications

• Hyslop C, "Much Ado About $500: Why the SCC Should Overturn Rogers v Voltage," (2018) 8:2 UWO J Leg Stud 4.
• Chan C et al., “Oligofructose as an Adjunct in Diabetes Treatment in NOD Mice,” Sci Rep.
• Hyslop C et al., “Prolactin as an Adjunct for Type 1 Diabetes Immunotherapy,” Endocrinology 157:1 (2016).
• Hyslop C et al., “Prolactin Improved Anti-CD3-Mediated Diabetes Cure in NOD Mice,” Can J Diabetes 38:5 (2014).
• Toselli C et al., “Non-β-Cell Contribution to β-Cell Mass During Pregnancy,” PloS one 9.6 (2014): e100398.

Awards

• Legate & Associates Malpractice Moot Winnder, 2017
• Hayes eLaw LLP Scholarship: Top Mark in Intellectual Property Law, 2017
• WeirFoulds LLP Writing Prize: Best Intellectual Property Law Paper, 2018